Inventurus Knowledge Solutions Ltd
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]
- Market Cap ₹ 31,630 Cr.
- Current Price ₹ 1,844
- High / Low ₹ 2,190 / 1,476
- Stock P/E 93.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 46.7 %
- ROE 45.9 %
- Face Value ₹ 1.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 46.7%
Cons
- Promoter holding has decreased over last quarter: -6.01%
- Debtor days have increased from 46.4 to 82.9 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: IT - Software Industry: Computers - Software - Medium / Small
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
161 | 203 | 388 | 418 | 560 | 759 | 873 | |
139 | 149 | 252 | 252 | 329 | 444 | 478 | |
Operating Profit | 22 | 54 | 136 | 166 | 231 | 316 | 394 |
OPM % | 14% | 27% | 35% | 40% | 41% | 42% | 45% |
0 | 0 | 31 | 16 | 1 | -3 | 33 | |
Interest | 8 | 8 | 7 | 7 | 6 | 5 | 16 |
Depreciation | 5 | 10 | 36 | 26 | 19 | 20 | 22 |
Profit before tax | 8 | 36 | 123 | 148 | 208 | 288 | 390 |
Tax % | 0% | 0% | 1% | 6% | 9% | 12% | 14% |
8 | 36 | 122 | 139 | 189 | 253 | 337 | |
EPS in Rs | 10.51 | 44.55 | 148.09 | 168.19 | 11.04 | 14.83 | 19.72 |
Dividend Payout % | 0% | 0% | 16% | 14% | 485% | 0% | 50% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 28% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 34% |
TTM: | 21% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 47% |
Last Year: | 46% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 8 | 17 | 17 | 17 |
Reserves | -40 | -2 | 221 | 368 | 501 | 622 | 811 |
74 | 79 | 0 | 62 | 53 | 43 | 227 | |
58 | 66 | 141 | 62 | 133 | 154 | 101 | |
Total Liabilities | 100 | 151 | 370 | 500 | 704 | 836 | 1,156 |
16 | 32 | 36 | 72 | 63 | 49 | 116 | |
CWIP | 14 | 26 | 0 | 0 | 0 | 0 | 0 |
Investments | 4 | 4 | 5 | 16 | 16 | 19 | 473 |
66 | 88 | 329 | 412 | 624 | 767 | 567 | |
Total Assets | 100 | 151 | 370 | 500 | 704 | 836 | 1,156 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
16 | 52 | 141 | 168 | 237 | 248 | 119 | |
-21 | -38 | -80 | -165 | -81 | -140 | -149 | |
5 | -2 | -36 | -32 | -54 | -148 | -186 | |
Net Cash Flow | 0 | 12 | 25 | -30 | 102 | -40 | -216 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 130 | 101 | 35 | 23 | 25 | 32 | 83 |
Inventory Days | |||||||
Days Payable | |||||||
Cash Conversion Cycle | 130 | 101 | 35 | 23 | 25 | 32 | 83 |
Working Capital Days | -16 | -22 | -6 | 10 | -48 | -34 | 55 |
ROCE % | 70% | 47% | 46% | 52% | 47% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - The officials of the Company shall be attending the Conference. The details of which is attached herewith.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Feb - Schedule of Analyst/Institutional Investor Meet on February 20, 2025.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12 Feb - Transcript of Q3 FY25 earnings conference call.
-
Newspaper Advertisement Confirming Dispatch Of Postal Ballot Notice
9 Feb - Newspaper advertisement confirming dispatch of Postal Ballot Notice.
- Newspaper Publication Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2024. 7 Feb
Concalls
-
Feb 2025Transcript PPT
Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a **fee for value model **